Patents by Inventor Marguerite Christine Koutsoukos

Marguerite Christine Koutsoukos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IMMUNOGENIC COMPOSITIONS
    Publication number: 20180360949
    Abstract: The invention provides, inter alia, compositions useful for, e.g., raising an immune response to HIV-1, and associated methods of raising an immune response to HIV in a mammalian subject. In some embodiments, the compositions are bivalent immunogenic compositions comprising two (or, in some embodiments more than two) human immunodeficiency virus (HIV) clade C envelope gp120 polypeptide antigens, together with a liposome-based adjuvant, such as the adjuvant known as AS01.
    Type: Application
    Filed: December 16, 2016
    Publication date: December 20, 2018
    Applicant: GLAXOSMITHKLINE BIOLOGICALS, SA
    Inventors: Susan BARNETT, Marguerite Christine KOUTSOUKOS, Clarisse Marie-Madeleine LORIN, Frederick PORTER, Zihao WANG, Ying ZHANG
  • HIV VACCINE
    Publication number: 20140234399
    Abstract: The present invention relates to immunogenic compositions comprising HIV-1 antigens and uses thereof in the prevention and/or treatment of HIV-1. In particular, the invention relates to the use of HIV-1 antigens from one clade in the prevention and/or treatment of disease associated with HIV-1 infection from a heterologous HIV-1 clade.
    Type: Application
    Filed: December 18, 2013
    Publication date: August 21, 2014
    Applicant: GlaxoSmithKline Biologicals, s.a.
    Inventors: Patricia BOURGUIGNON, Marguerite Christine Koutsoukos, Clarisse Lorin, Lisa McNally, Gerald Hermann Voss
  • VACCINE
    Publication number: 20130280322
    Abstract: The present invention provides methods and compositions for the treatment of HIV-1 infected subjects. The invention relates in particular to enhancing the immune response of an infected subject and to stabilising or reducing the viral load of an infected subject.
    Type: Application
    Filed: September 27, 2011
    Publication date: October 24, 2013
    Applicant: GlaxoSmithKline Biologicals S.A.
    Inventors: Marguerite Christine Koutsoukos, Patricia B. Bourguignon, Gerald Hermann Voss